{"name": "Intercytex Group",
 "permalink": "intercytex-group",
 "crunchbase_url": "http://www.crunchbase.com/company/intercytex-group",
 "homepage_url": "http://www.intercytex.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 77,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "44 16 1904 4500",
 "description": "",
 "created_at": "Thu Sep 03 11:10:18 UTC 2009",
 "updated_at": "Thu Sep 03 11:12:39 UTC 2009",
 "overview": "\u003Cp\u003EIntercytex Group plc, a development stage biotechnology company, engages in the research, development, and commercialization of cell-based therapies for the repair and regeneration of skin and hair. The company, using its integrated cell technology platform, develops living, human cell-based products. Its product programs in development include VAVELTA, a facial rejuvenation and skin damage repair product, which completed Phase II trials; SHEF-1-Stem Cell Line, which would develop a cure for AMD, the leading cause of blindness in the elderly; ICX-TRC, a hair regeneration product that completed Phase II trials; and ICX-SKN, a skin graft replacement for burns and acute wounds, which completed Phase I trial. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[100,
       78],
      "assets/images/resized/0005/8670/58670v1-max-150x150.png"],
     [[100,
       78],
      "assets/images/resized/0005/8670/58670v1-max-250x250.png"],
     [[100,
       78],
      "assets/images/resized/0005/8670/58670v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Nick",
      "last_name": "Higgins",
      "permalink": "nick-higgins",
      "image": null}},
   {"is_past": false,
    "title": "Founder",
    "person":
     {"first_name": "Paul",
      "last_name": "Kemp",
      "permalink": "paul-kemp",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 2550000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "",
    "source_description": "",
    "acquired_year": 2008,
    "acquired_month": 12,
    "acquired_day": 22,
    "company":
     {"name": "Axordia",
      "permalink": "axordia",
      "image": null}}],
 "offices":
  [{"description": "",
    "address1": "St Johns Innovation Centre",
    "address2": "Cowley Road",
    "zip_code": "CB4 0WS",
    "city": "Cambridge",
    "state_code": null,
    "country_code": "GBR",
    "latitude": 52.2309912,
    "longitude": 0.1295545}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}